There is no controlled data as yet to confirm a specific link between peripheral pMAPK assay and neural Ras function in human NF1 (although links have been found in cognitive impairment and Alzheimer’s disease); further work will be necessary to confirm its value as a biomarker. This evidence concerns the gene NF1 and early-onset autosomal dominant Alzheimer disease.